Shared from michaeljfox.org.
The U.S. Food and Drug Administration has approved a treatment that uses focused ultrasound on both sides of the brain (in two procedures, months apart) for the management of Parkinson’s-related movement, or motor, symptoms.
The approval is an advance in focused ultrasound (FUS) treatment, a noninvasive surgical approach that uses sound waves to create heat and destroy a small area of brain tissue involved in Parkinson’s. But until this latest advance, FUS could only be performed on one side of the brain and therefore only improved symptoms on one side of the body. The new approach targets a different area of the brain, making it available to treat both sides of the brain, and therefore to treat tremor, slowness, stiffness and involuntary movement (dyskinesia) on both sides of the body.